Sandford D. Smith - 19 Jul 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
By: Robert Wong For: Sandford Smith
Issuer symbol
CYTK
Transactions as of
19 Jul 2021
Net transactions value
-$217,681
Form type
4
Filing time
21 Jul 2021, 17:14:49 UTC
Previous filing
08 Jul 2021
Next filing
04 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $53,400 +5,000 +77% $10.68 11,459 19 Jul 2021 Direct F1, F2
transaction CYTK Common Stock Sale $145,000 -5,000 -44% $29.00 6,459 19 Jul 2021 Direct F1, F2
transaction CYTK Common Stock Options Exercise $20,986 +1,965 +30% $10.68 8,424 19 Jul 2021 Direct F1, F2
transaction CYTK Common Stock Sale $57,968 -1,965 -23% $29.50 6,459 19 Jul 2021 Direct F1, F2
transaction CYTK Common Stock Options Exercise $53,400 +5,000 +77% $10.68 11,459 19 Jul 2021 Direct F1, F2
transaction CYTK Common Stock Sale $142,500 -5,000 -44% $28.50 6,459 19 Jul 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,000 -33% $0.000000 10,000 19 Jul 2021 Common Stock 5,000 $10.68 Direct F1
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,965 -20% $0.000000 8,035 19 Jul 2021 Common Stock 1,965 $10.68 Direct F1
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,000 -62% $0.000000 3,035 19 Jul 2021 Common Stock 5,000 $10.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021.
F2 Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.